Seroprevalence of GB virus C and persistence of RNA and antibody

Journal of Medical Virology

Volumn 53, Issue 2, 1997, Pages 167-173

  Gutierrez, Robin A ^a,d   Dawson, George J ^a   Knigge, Mark F ^a   Melvin, Susan L ^a   Heynen, Cynthia A ^a   Kyrk, Charles R ^a   Young, Charles E ^a   Carrick, Robert J ^a   Schlauder, George G ^a   Surowy, Teresa K ^a   Dille, Bruce J ^a   Coleman, Paul F ^a   Thiele, Dwain L ^b   Lentino, Joseph R ^c   Pachucki, Constance ^c   Mushahwar, Isa K ^a  

^a ABBOTT LABORATORIES   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c HINES VA HOSPITAL   (United States)

^d Virus Discovery Group   (United States)

Author keywords

ELISA; GBV C E2; Hepatitis; RT PCR

Indexed keywords

ARTICLE; BLOOD DONOR; CONTROLLED STUDY; FLAVIVIRUS; HEPATITIS; HEPATITIS G VIRUS; HUMAN; MAJOR CLINICAL STUDY; PLASMAPHERESIS; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROPREVALENCE; UNITED STATES; VIRUS CHARACTERIZATION; VIRUS DETECTION; VIRUS INFECTION;

ACUTE DISEASE; BLOOD DONORS; BLOOD TRANSFUSION; FLAVIVIRIDAE; HEPATITIS ANTIBODIES; HEPATITIS C; HEPATITIS C, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; PLASMA; RNA, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS;

FLAVIVIRUS; GB VIRUS C/HEPATITIS G VIRUS; MAMMALIA;

EID: 0030765662     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199710)53:2<167::AID-JMV10>3.0.CO;2-G     Document Type: Article

References (25)

1. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JW-K, Kim JP (1997): The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. The New England Journal of Medicine 336:747-754.
2. Dawson GJ, Schlauder GG, Pilot-Matias TJ, Thiele D, Leary TP, Murphy P, Rosenblatt JE, Simons JN, Martinson FE, Gutierrez RA, Lentino JR, Pachucki C, Muerhoff AS, Widell A, Tegtmeier G, Desai SM, Mushahwar IK (1996): Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction. Journal of Medical Virology 50:97-103.
3. Dawson GJ, Leary TP, Desai SM, Surowy TK, Carrick RJ, Schlauder GG, Gabriel GS, Heynen CA, Gutierrez RA, Knigge MF, Kyrk CR, Young CE, Coleman PP, Dille BJ, Mushahwar IK (1997): GBV-C Prevalence studies. In Rizzetto, M (ed): "Viral Hepatitis and Liver Disease."
4. Dille BJ, Surowy TK, Gutierrez RA, Coleman PF, Knigge, MF, Carrick RJ, Aach RD, Hollinger FB, Stevens CE, Barbosa LH, Nemo GJ, Mosley JW, Dawson GJ, Mushahwar IK (1997): An ELISA for detection of antibodies to the E2 protein of GB virus C. The Journal of Infectious Diseases 175:458-461.
5. Jarvis LM, Davidson F, Hanley JP, Yap PL, Ludlam CA, Simmonds P (1996): Infection with hepatitis G virus among recipients of plasma products. The Lancet 348:1352-1355.
6. Kleinman S, Alter H, Busch M, Holland P, Tegtmeier G, Nelles M, Lee S, Page E, Wilber J, Polito A (1992): Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion 32:805-813.
7. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, Dawson GJ, Desai SM, Mushahwar IK (1996a): Sequence and genomic organization of GBV-C: A novel member of the Flaviviridae associated with human non A-E hepatitis. Journal of Medical Virology 48:60-67.
8. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, Dawson GJ, Desai SM, Mushahwar IK (1996b): Consensus oligonucleotide primers for the detection of GB virus C in human cryptogenic hepatitis. Journal of Virological Methods 56:119-121.
9. Leary TP, Muerhoff AS, Schlauder GG, Marshall RL, Pilot-Matias TJ, Simons JN, Dawson GJ, Desai SM, Mushahwar IK (1997): Molecular diagnostic assays for the detection of GB virus C Infection. In Rizzetto, M (ed): "Viral Hepatitis and Liver Disease."
10. Lee SR, Wood CL, Lane MJ, Francis B, Gust C, Higgs CM, Nelles MJ, Polito A, DiNello R, Achord D (1995): Increased detection of hepatitis C virus infection in commercial plasma donors by a third-generation screening assay. Transfusion 35:845-849.
11. Lesniewski R, Okasinski G, Carrick R, VanSant C, Desai S, Johnson R, Scheffel J, Moore B, Mushahwar IK (1995): Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: A new marker of HCV infection closely associated with viremia. Journal of Medical Virology 45:415-422.
12. Linnen J, Wages J, Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis S, Karayiannis P, Fung K, Nakatsuji Y, Shih JW-K, Young L, Piatak JM, Hoover C, Fernandez J, Chen S, Zou J-C, Morris T, Hyams KC, Ismay S, Lifson JD, Hess G, Foung SKH, Bradley TH, Margolis H, Kim JP (1996): Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271:505-509.
13. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, Murayama N, Inoue T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M (1996): Infection with hepatitis GB virus C in patients on maintenance hemodialysis. The New England Journal of Medicine 334:1485-1490.
14. Muerhoff AS, Leary TP, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, Dawson GJ, Desai SM, Mushahwar IK (1995): Genomic organization of GBV-A and GBV-B: Two new members of the Flaviviridae associated with GB-agent hepatitis. Journal of Virology 69:5622-5630.
15. Muerhoff AS, Simons JN, Erker JC, Desai SM, Mushahwar IK (1996): Identification of conserved nucleotide sequences within the GB virus C 5′-untranslated region: Design of PCR primers for detection of viral RNA. Journal of Virological Methods 62:55-62.
16. Nubling CM, Lower J (1996): GB-C genomes in a high-risk group, in plasma pools and in intravenous immunoglobulin. The Lancet 347:68.
17. Pilot-Matias TJ, Muerhoff AS, Simons JN, Leary TP, Buijk SL, Chalmers ML, Erker JC, Dawson GJ, Desai SM, Mushahwar IK (1996a): Identification of antigenic regions in the GB hepatitis viruses GBV-A, GBV-B and GBV-C. Journal of Medical Virology 48:329-338.
18. Pilot-Matias TJ, Carrick RJ, Coleman PF, Leary TP, Surowy TK, Simons JN, Muerhoff AS, Buijk SL, Chalmers ML, Dawson GJ, Desai SM, Mushahwar IK (1996b): Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker. Virology 225:282-292.
19. Schlauder GG, Dawson GJ, Simons JN, Pilot-Matias TJ, Gutierrez RA, Heynen CA, Knigge MF, Kurpiewski GS, Buijk SL, Leary TP, Muerhoff AS, Desai SM, Mushahwar IK (1995): Molecular and serologic analysis in the transmission of the GB hepatitis agents. Journal of Medical Virology 46:81-90.
20. Schleicher S, Chaves RL, Dehmer T, Gregor M, Hess G, Flehmig B (1996): Identification of GBV-C Hepatitis G RNA in chronic hepatitis C patients. Journal of Medical Virology 50:71-74.
21. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, Muerhoff AS, Erker JC, Buijk SL, Chalmers MI, Van Sant CL, Mushahwar IK (1995a): Identification of two flavivirus-like genomes in the GB hepatitis agent. Proceedings of the National Academy of Sciences USA 92:3401-3405.
22. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK (1995b): Isolation of novel virus-like sequences associated with human hepatitis. Nature Medicine 1:564-569.
23. Surowy TK, Leary TP, Carrick RJ, Knigge MF, Pilot-Matias TJ, Heynen CA, Gutierrez RA, Desai SM, Dawson GJ, Mushahwar IK (1997): GB virus C E2 glycoprotein: Expression in CHO cells, purification and characterization. Journal of General Virology 78:1851-1859.
24. Tacke M, Kiyosawa K, Stark K, Schlueter V, Ofenloch-Haehnle B, Hess G (1997): Detection of antibodies to a putative hepatitis G virus envelope protein. The Lancet 349:318-320.
25. Zuckerman AJ (1996): Alphabet of hepatitis viruses. The Lancet 347: 558-559.